• 2024
  Gedeon A, Yab E, Dinut A, Sadowski E, Capton E, Dreneau A, Petit J, Gioia B, Piveteau C, Djaout K, Lecat E, Wehenkel AM, Gubellini F, Mechaly A, Alzari PM, Deprez B, Baulard A, Aubry A, Willand N, Petrella S, Molecular mechanism of a triazole-containing inhibitor of Mycobacterium tuberculosis DNA gyrase., iScience 2024 Oct; 27(10): 110967.
• 2023
  Weiß M, Giacomelli G, Assaya MB, Grundt F, Haouz A, Peng F, Petrella S, Wehenkel AM, Bramkamp M, The MksG nuclease is the executing part of the bacterial plasmid defense system MksBEFG., Nucleic Acids Res 2023 Apr; 51(7): 3288-3306.
• 2022
  Takahashi DT, Gadelle D, Agama K, Kiselev E, Zhang H, Yab E, Petrella S, Forterre P, Pommier Y, Mayer C, , Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states., Nat Commun 2022 01; 13(1): 59.
• 2021
  Chauffour A, Morel F, Reibel F, Petrella S, Mayer C, Cambau E, Aubry A, , A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance., Clin Microbiol Infect 2021 Nov; 27(11): 1601-1612.
• 2020
  Bruch, E.M., Petrella, S., Bellinzoni, M., Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead, Appl. Sci. 2020; 10(12):4248.
• 2019
  Petrella S, Capton E, Raynal B, Giffard C, Thureau A, Bonneté F, Alzari PM, Aubry A, Mayer C, Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity, Structure 2019 04;27(4):579-589.e5.
• 2016
  Brossier F, Boudinet M, Jarlier V, Petrella S, Sougakoff W, Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis, Tuberculosis (Edinb) 2016 09;100:15-24.
• 2016
  Pantel A, Petrella S, Veziris N, Matrat S, Bouige A, Ferrand H, Sougakoff W, Mayer C, Aubry A, Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis, J. Antimicrob. Chemother. 2016 May;.
• 2016
  Stéphanie Petrella, Alexandra Aubry, Geneviève Janvier, Eloi Paul Coutant, Alex Cartier, Thuy-Ha Dao, Frédéric Bonhomme, Laurence Motreff, Cédric Pissis, Chantal Bizet, Dominique Clermont, Evelyne Begaud, Pascal Retailleau, Hélène Munier-Lehmann, Estelle Capton, Claudine Mayer, Yves Janin, Synthesis and evaluation of original bioisosteres of bacterial type IIA topoisomerases inhibitors, Can. J. Chem. 2016, 94 , 240-250.
• 2013
  Agrawal A, Roué M, Spitzfaden C, Petrella S, Aubry A, Hann M, Bax B, Mayer C, Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion, Biochem. J. 2013 Dec;456(2):263-73.
• 2013
  Bouige A, Darmon A, Piton J, Roue M, Petrella S, Capton E, Forterre P, Aubry A, Mayer C, Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes, Biochem. J. 2013 Nov;455(3):285-94.
• 2012
  Segala E, Sougakoff W, Nevejans-Chauffour A, Jarlier V, Petrella S, New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure, Antimicrob. Agents Chemother. 2012 May;56(5):2326-34.
• 2012
  Pantel A, Petrella S, Veziris N, Brossier F, Bastian S, Jarlier V, Mayer C, Aubry A, Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis, Antimicrob. Agents Chemother. 2012 Apr;56(4):1990-6.
• 2012
  Darmon A, Piton J, Roué M, Petrella S, Aubry A, Mayer C, Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTD, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2012 Feb;68(Pt 2):178-80.
• 2011
  Pantel A, Petrella S, Matrat S, Brossier F, Bastian S, Reitter D, Jarlier V, Mayer C, Aubry A, DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 2011 Oct;55(10):4524-9.
• 2011
  Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W, Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide, PLoS ONE 2011;6(1):e15785.
• 2010
  Piton J, Petrella S, Delarue M, André-Leroux G, Jarlier V, Aubry A, Mayer C, Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase, PLoS ONE 2010 Aug;5(8):e12245.
• 2010
  Bonnafous P, Verbelen M, Petrella S, Deback C, Gautheret-Dejean A, Boutolleau D, Naesens L, Agut H, Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development, Antiviral Res. 2010 Jun;86(3):316-9.
• 2009
  Kerff F, Petrella S, Mercier F, Sauvage E, Herman R, Pennartz A, Zervosen A, Luxen A, Frère JM, Joris B, Charlier P, Specific structural features of the N-acetylmuramoyl-L-alanine amidase AmiD from Escherichia coli and mechanistic implications for enzymes of this family, J. Mol. Biol. 2010 Mar;397(1):249-59.
• 2009
  Piton J, Matrat S, Petrella S, Jarlier V, Aubry A, Mayer C, Purification, crystallization and preliminary X-ray diffraction experiments on the breakage-reunion domain of the DNA gyrase from Mycobacterium tuberculosis, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2009 Nov;65(Pt 11):1182-6.
• 2008
  Kerff F, Amoroso A, Herman R, Sauvage E, Petrella S, Filée P, Charlier P, Joris B, Tabuchi A, Nikolaidis N, Cosgrove DJ, Crystal structure and activity of Bacillus subtilis YoaJ (EXLX1), a bacterial expansin that promotes root colonization, Proc. Natl. Acad. Sci. U.S.A. 2008 Nov;105(44):16876-81.
• 2008
  Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W, Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France, Antimicrob. Agents Chemother. 2008 Oct;52(10):3725-36.
• 2007
  Sauvage E, Duez C, Herman R, Kerff F, Petrella S, Anderson JW, Adediran SA, Pratt RF, Frère JM, Charlier P, Crystal structure of the Bacillus subtilis penicillin-binding protein 4a, and its complex with a peptidoglycan mimetic peptide, J. Mol. Biol. 2007 Aug;371(2):528-39.
• 2007
  Matrat S, Petrella S, Cambau E, Sougakoff W, Jarlier V, Aubry A, Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones, Antimicrob. Agents Chemother. 2007 May;51(5):1643-8.
• 2007
  Bonnafous P, Naesens L, Petrella S, Gautheret-Dejean A, Boutolleau D, Sougakoff W, Agut H, Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet, Antivir. Ther. (Lond.) 2007;12(6):877-88.
• 2006
  Petrella S, Cambau E, Chauffour A, Andries K, Jarlier V, Sougakoff W, Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria, Antimicrob. Agents Chemother. 2006 Aug;50(8):2853-6.
• 2005
  Sauvage E, Herman R, Petrella S, Duez C, Bouillenne F, Frère JM, Charlier P, Crystal structure of the Actinomadura R39 DD-peptidase reveals new domains in penicillin-binding proteins, J. Biol. Chem. 2005 Sep;280(35):31249-56.
• 2003
  Petrella S, Pernot L, Sougakoff W, Crystallization and preliminary X-ray diffraction study of the class A beta-lactamase SED-1 and its mutant SED-G238C from Citrobacter sedlakii, Acta Crystallogr. D Biol. Crystallogr. 2004 Jan;60(Pt 1):125-8.
• 2001
  Petrella S, Clermont D, Casin I, Jarlier V, Sougakoff W, Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus, Antimicrob. Agents Chemother. 2001 Aug;45(8):2287-98.
• 2001
  Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W, Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem, J. Mol. Biol. 2001 Jul;310(4):859-74.